CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 9 No. 6
 

Radiotherapy Delay After Lumpectomy Reduces Disease-Free Survival in Indigent Black Women

June 1, 2000

CHICAGO—Breast conservation followed by radiotherapy is an effective treatment approach for invasive breast cancer in medically indigent black women, but prompt initiation of the radiotherapy and adequate radiation dose are necessary to achieve optimal results, according to a study presented at the 85th Annual Meeting of the Radiological Society of North America (RSNA).

In this study, women who received radiotherapy within 30 days of lumpec-tomy had superior disease-free survival, compared with those in whom radiotherapy was delayed. Women who received a dose of at least 50 Gy achieved a greater degree of local control as well as longer disease-free and overall survival than those given lower doses, said Stuart H. Burri, MD, chief resident in Radiation Oncology, Emory University.

Dr. Burri and his colleagues reviewed the records of 88 black women who underwent breast-conservation therapy between 1980 and 1996 at Emory’s Grady Memorial Hospital. Most were uninsured or receiving Medicaid. Of these 88 women, 72 had invasive cancer: 56% stage I disease; 37.5% stage II; 5.6% stage III; and 33% had positive lymph nodes.

Following lumpectomy, radiotherapy was delivered to the involved breast by means of opposed tangents. The dose ranged from 45 to 55 Gy (median, 50 Gy), and 70% received a radiation boost (median dose, 10 Gy). Radiotherapy was delivered between 9 and 312 days after lumpectomy (median, 69 days). The average follow-up was 55.4 months.

The proportion of women with invasive breast cancer who had local control of their disease was 95% at 5 years and 88% at 10 years. Disease-free survival was 85% at 5 years and 65% at 10 years, and overall survival was 77% at 5 years and 43% at 10 years.

Local control, disease-free survival, and overall survival were inferior among women who received a radiotherapy dose to the tumor bed of less than 50 Gy (P < .0001). Treatment failure was more likely if radiotherapy was delayed for more than 30 days after lumpectomy (P = .0479).

Dr. Burri explained that the method of notifying patients of the need for radiotherapy was most likely responsible for the extended intervals between surgery and further treatment experienced by some patients. Patients typically were notified by mail to return for further therapy after lumpectomy, but indigent patients can be difficult to contact by mail, because they tend to move frequently or do not have a mailing address.

Mailings also have been delayed by inefficiencies in the hospital mailing system. “We have made efforts in recent years to decrease that time, and it has improved recently,” Dr. Burri said.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy